1. Amphiphysin-positive paraneoplastic myelitis and stiff-person syndrome. Issue 6 (December 2016) Authors: Faissner, Simon; Lukas, Carsten; Reinacher-Schick, Anke; Tannapfel, Andrea; Gold, Ralf; Kleiter, Ingo Journal: Neurology Issue: Volume 3:Issue 6(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bortezomib in severe MuSK-antibody positive myasthenia gravis: first clinical experience. (October 2017) Authors: Schneider-Gold, Christiane; Reinacher-Schick, Anke; Ellrichmann, Gisa; Gold, Ralf Journal: Therapeutic advances in neurological disorders Issue: Volume 10:Number 10(2017) Page Start: 339 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Docetaxel, oxaliplatin and capecitabine (TEX regimen) in patients with metastatic gastric or gastro-esophageal cancer: Results of a multicenter phase I/II study. (March 2014) Authors: Stein, Alexander; Arnold, Dirk; Thuss-Patience, Peter C.; Moehler, Markus; Grothe, Wilfried; Seufferlein, Thomas; Reinacher-Schick, Anke; Geissler, Michael; Hofheinz, Ralf-Dieter; Schmoll, Hans-Joachim Journal: Acta oncologica Issue: Volume 53:Number 3(2014) Page Start: 392 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Dose-dependent immunomodulatory effects of bortezomib in experimental autoimmune neuritis. Issue 4 (9th October 2021) Authors: Klimas, Rafael; Sgodzai, Melissa; Motte, Jeremias; Mohamad, Nuwin; Renk, Pia; Blusch, Alina; Grüter, Thomas; Pedreiturria, Xiomara; Gobrecht, Philipp; Fischer, Dietmar; Schneider-Gold, Christiane; Reinacher-Schick, Anke; Tannapfel, Andrea; Yoon, Min-Suk; Gold, Ralf; Pitarokoili, Kalliopi Journal: Brain communications Issue: Volume 3:Issue 4(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Fast and label-free automated detection of microsatellite status in early colon cancer using artificial intelligence integrated infrared imaging. (March 2023) Authors: Gerwert, Klaus; Schörner, Stephanie; Großerueschkamp, Frederik; Kraeft, Anna–Lena; Schuhmacher, David; Sternemann, Carlo; Feder, Inke S.; Wisser, Sarah; Lugnier, Celine; Arnold, Dirk; Teschendorf, Christian; Mueller, Lothar; Timmesfeld, Nina; Mosig, Axel; Reinacher-Schick, Anke; Tannapfel, Andrea Journal: European journal of cancer Issue: Volume 182(2023) Page Start: 122 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Impact of primary tumour location and RAS/BRAF mutational status in metastatic colorectal cancer treated with first-line regimens containing oxaliplatin and bevacizumab: Prognostic factors from the AIO KRK0207 first-line and maintenance therapy trial. (September 2018) Authors: Hegewisch-Becker, Susanna; Nöpel-Dünnebacke, Stefanie; Hinke, Axel; Graeven, Ullrich; Reinacher-Schick, Anke; Hertel, Jan; Lerchenmüller, Christian A.; Killing, Birgitta; Depenbusch, Reinhard; Al-Batran, Salah-Eddin; Lange, Thoralf; Dietrich, Georg; Tannapfel, Andrea; Arnold, Dirk Journal: European journal of cancer Issue: Volume 101(2018) Page Start: 105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial. Issue 13 (October 2015) Authors: Hegewisch-Becker, Susanna; Graeven, Ullrich; Lerchenmüller, Christian A; Killing, Birgitta; Depenbusch, Reinhard; Steffens, Claus-Christoph; Al-Batran, Salah-Eddin; Lange, Thoralf; Dietrich, Georg; Stoehlmacher, Jan; Tannapfel, Andrea; Reinacher-Schick, Anke; Quidde, Julia; Trarbach, Tanja; Hinke... Journal: Lancet oncology Issue: Volume 16:Issue 13(2015) Page Start: 1355 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer. Issue 34 (1st December 2022) Authors: Kindler, Hedy L.; Hammel, Pascal; Reni, Michele; Van Cutsem, Eric; Macarulla, Teresa; Hall, Michael J.; Park, Joon Oh; Hochhauser, Daniel; Arnold, Dirk; Oh, Do-Youn; Reinacher-Schick, Anke; Tortora, Giampaolo; Algül, Hana; O'Reilly, Eileen M.; Bordia, Sonal; McGuinness, David; Cui, Karen; Locker,... Journal: Journal of clinical oncology Issue: Volume 40:Issue 34(2022) Page Start: 3929 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Panitumumab Plus Fluorouracil and Folinic Acid Versus Fluorouracil and Folinic Acid Alone as Maintenance Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Randomized PANAMA Trial (AIO KRK 0212). Issue 1 (1st January 2022) Authors: Modest, Dominik Paul; Karthaus, Meinolf; Fruehauf, Stefan; Graeven, Ullrich; Müller, Lothar; König, Alexander Otto; Fischer von Weikersthal, Ludwig; Caca, Karel; Kretzschmar, Albrecht; Goekkurt, Eray; Haas, Siegfried; Kurreck, Annika; Stahler, Arndt; Held, Swantje; Jarosch, Armin; Horst, David; R... Journal: Journal of clinical oncology Issue: Volume 40:Issue 1(2022) Page Start: 72 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Serial Circulating Tumor DNA Mutational Status in Patients with KRAS-Mutant Metastatic Colorectal Cancer from the Phase 3 AIO KRK0207 Trial. (29th November 2020) Authors: Lueong, Smiths S; Herbst, Andreas; Liffers, Sven-Thorsten; Bielefeld, Nicola; Horn, Peter A; Tannapfel, Andrea; Reinacher-Schick, Anke; Hinke, Axel; Hegewisch-Becker, Susanna; Kolligs, Frank T; Siveke, Jens T Journal: Clinical chemistry Issue: Volume 66:Number 12(2020) Page Start: 1510 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗